Buprenorphine Extended-Release Injection and Dexrazoxane Intravenous
Determining the interaction of Buprenorphine Extended-Release Injection and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Dextenza Insert
- Buprenorphine Extended-Release Injection-Dextenza intraocular
- Buprenorphine Extended-Release Injection-Dextran 40
- Buprenorphine Extended-Release Injection-Dextran 70 6% in 5% Dextrose high molecular weight
- Buprenorphine Extended-Release Injection-Dextran 75
- Buprenorphine Extended-Release Injection-Dextran high molecular weight
- Dexrazoxane Intravenous-Buprenorphine implant
- Dexrazoxane Intravenous-Buprenorphine Injection
- Dexrazoxane Intravenous-Buprenorphine injection - Buprenex
- Dexrazoxane Intravenous-Buprenorphine injection - Sublocade
- Dexrazoxane Intravenous-Buprenorphine Intradermal
- Dexrazoxane Intravenous-Buprenorphine oral/buccal